Reta fresh

Reta fresh Pen is a fundamentally new, revolutionary pharmacological agent purposefully and specifically developed for the most effective reduction of excess body weight, as well as for guaranteed long-term maintenance of achieved healthy weight. The medication is produced in an innovative form of high-tech disposable pen-injectors (pen syringes) designed for patients' self-subcutaneous administration directly at home. This release form provides exceptional comfort, absolute hygiene, and utmost simplicity of use without the need for frequent visits to medical facilities.

The active ingredient of this medicinal product is a complex synthetic substance that represents a highly purified analogue of the natural human hormone glucagon-like peptide-1 (GLP-1).

The GLP-1 hormone is naturally synthesized and secreted by endocrine L-cells of the human body immediately after food intake. It plays a key role in the complex system of metabolic homeostasis: it participates in the fine regulation of blood sugar (glucose) levels, stimulates timely insulin secretion by pancreatic beta-cells during hyperglycemia, significantly slows down the physiological process of stomach emptying from chyme, and exerts powerful central action on satiety centers in the hypothalamus, effectively suppressing hunger.

Properties and Mechanism of Action

The uniqueness of the drug lies in its multicomponent mechanism of triple activation of specific hormonal receptors:

• GLP-1 Receptors: provide pronounced appetite suppression through CNS impact and significant slowing of gastric motility and emptying, which prolongs the physical sensation of fullness.

• GIP (Glucose-dependent Insulinotropic Polypeptide) Receptors: stimulate increased production of own insulin and enhance overall sensitivity of peripheral tissues to this hormone, optimizing carbohydrate metabolism.

• Glucagon Receptors (GCGR): trigger powerful lipolysis processes (breakdown of fat cells), increase thermogenesis (generation of internal heat by the body), and significantly raise general daily energy expenditure even at rest.

Thus, regular course administration of Reta fresh Pen allows not only to mimic the action of endogenous (own) GLP-1 but also to comprehensively modulate metabolism. This multiple times enhances natural control over appetite, radically reduces psychological cravings for overeating, night snacking, and consumption of high-calorie foods, and accelerates the metabolism of visceral and subcutaneous adipose tissue. Thanks to such deep systemic impact, patients note not only systematic loss of extra pounds but also significant improvement in general well-being, normalization of blood pressure indicators, disappearance of shortness of breath under exertion, and a radical improvement in quality of life.

The use of this innovative drug contributes to the natural formation of healthy habits of conscious eating, deep normalization of the body's energy balance, prevents dangerous gain of new kilograms after completing the treatment course, and serves as an effective measure for preventing severe concomitant diseases. These include type 2 diabetes mellitus, chronic arterial hypertension, atherosclerotic vascular lesions, coronary heart disease, and other cardiovascular pathologies.

To achieve a synergistic effect in clinical practice, the following combined therapy protocols (stacks) are applied:

Popularity and Status as of 2026: Unconditional Market Leader (#1 Weight Loss Drug). According to global search query analytics, interest in the drug has grown by more than 720%, indicating a paradigm shift in treating excess weight. Clinical studies confirm that it surpasses all existing market drugs of the GLP-1 class (semaglutides, tirzepatides of previous generations) absolutely across all key parameters of efficacy, safety, and tolerability. In the professional environment, this breakthrough has already received the unofficial name "The End of Obesity as a Disease."

Reta fresh is officially approved by the international medical community as a completely new gold standard of modern metabolic therapy.